You have landed on a page of the archived Cochrane Community website. This site is not being maintained or updated.

If you are looking for Cochrane Review evidence, please visit Cochrane’s evidence page.

If you are a Cochrane contributor looking for Community resources, please visit the new Cochrane Community website.

Biologics for rheumatoid arthritis: an overview of Cochrane reviews

Warning: Parameter 2 to onepixelout_swftools_flashvars() expected to be a reference, value given in module_invoke() (line 476 of /var/www/archive/includes/

To browse Podcasts by topic, please visit the new Cochrane Summaries site here

Cochrane overviews are a new type of article in The Cochrane Library, combining the findings from multiple reviews. One of the first investigates a class of drugs called biologics for rheumatoid arthritis. Jasvinder Singh, the lead author who is based at the Minneapolis Veterans Affairs Medical Center in the US talks to Chris Mavergames from the German Cochrane Centre about this collection of evidence

Play Now!

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Download [mp3]  | Read Review
Updated on: April 30, 2014, 10:40

Comments for improvement or correction are welcome.